Our highly motivated and educated CRA team guarantee reliable data for your new drug submission. AstraClinical experts are committed to highest quality and subsequently has implemented ongoing co-monitoring and accompanied visits by a dedicated trainer and senior staff for their CRAs in order to ensure compliance with local laws and international regulations and guidelines. Using a defined process we are able to identify potential issues in a timely manner and support our CRAs with their skills and professional development.
Monitoring activities conducted by Clinical Research Associates (CRA) are regarded as one of the most important part in the conduct of a new drug development. Our CRAs are skilled and well trained to ensure a highest quality review of your study data and to interact effectively with the study sites. Our CRAs are the main communication link between site and study sponsor. The main tasks of our CRAs during a clinical study site visit are: